메뉴 건너뛰기




Volumn 14, Issue 6, 2006, Pages 1838-1850

Novel vitamin D3 antipsoriatic antedrugs: 16-En-22-oxa-1α, 25-(OH)2D3 analogs

Author keywords

16 En 22 oxa 1 ,25 dihydroxyvitamin D3 analogs; Antedrug; Low calcemic activity; Psoriasis

Indexed keywords

1ALPHA,3BETA DIHYDROXY 20 (3 HYDROXY 3 METHYLBUTYLOXY) 9,10 SECOPREGNA 5,7,10(19),16 TETRAENE; 1ALPHA,3BETA DIHYDROXY 20 (4 HYDROXY 4 METHYL 2 PENTENYLOXY) 9,10 SECOPREGNA 5,7,10(19),16 TETRAENE; 1ALPHA,3BETA DIHYDROXY 20 (4 HYDROXY 4 METHYL 2 PENTYLYLOXY) 9,10 SECOPREGNA 5,7,10(19),16 TETRAENE; 1ALPHA,3BETA DIHYDROXY 20 (4 HYDROXY 4 METHYLPENTYL OXY) 9,10 SECOPREGNA 5,7,10(19),16 TETRAENE; 1ALPHA,3BETA DIHYDROXY 20 (4 HYDROXY 4 METHYLPENTYLOXY) 9,10 SECOPREGNA 5,7,10(19),16 TETRAENE; 1ALPHA,3BETA DIHYDROXY 20 HYDROXY 9,10 SECOPREGNA 5,7,10(19),16 TETRAENE; 1ALPHA,3BETA DIHYDROXY 20[(4 HYDROXY 4 METHYL 2 PENTENYLOXY)] 9,10 SECOPREGNA 5,7,10(19),16 TETRAENE; ANTIPSORIASIS AGENT; COLECALCIFEROL; UNCLASSIFIED DRUG; DRUG DERIVATIVE; VITAMIN D;

EID: 32044435347     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2005.10.034     Document Type: Article
Times cited : (9)

References (29)
  • 18
    • 32044469466 scopus 로고    scopus 로고
    • JP Patent 10-231284, 1998.
    • Kawase, A. JP Patent 10-231284, 1998.
    • Kawase, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.